Weiss Multi-Strategy Advisers’s AstraZeneca AZN Stock Holding History

Weiss Multi-Strategy Advisers’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-2,250	Closed	-$201K	–	538
2020 Q1	$201K	Buy	+2,250	New	+$212K	0.01%	389
2017 Q2	–	Sell	-12,500	Closed	-$779K	–	520
2017 Q1	$779K	Buy	12,500 +2,500	+25%	+$146K	0.03%	418
2016 Q4	$546K	Buy	+10,000	New	+$568K	0.03%	317

Other funds holding AZN

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Weiss Multi-Strategy Advisers's AZN Position: Q1 2024 in Review

Weiss Multi-Strategy Advisers sold out of AstraZeneca (AZN) in Q1 2024, closing a stake of 5,725 shares — an estimated $771K sold.

Weiss Multi-Strategy Advisers first reported a position in AZN in Q2 2013 and held it in 40 quarters. The position peaked at $11.4M in Q3 2022. 1,141 funds tracked by Wall St. Rank hold AZN as of Q1 2024.

Weiss Multi-Strategy Advisers reported no remaining AstraZeneca position as of Q1 2024 after selling out during the quarter.
Weiss Multi-Strategy Advisers sold 5,725 AstraZeneca shares in Q1 2024, an estimated $771K.
Weiss Multi-Strategy Advisers first reported a position in AstraZeneca in Q2 2013 and held it in 40 quarters.
Weiss Multi-Strategy Advisers's AstraZeneca position peaked at $11.4M in Q3 2022.
1,141 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2024.

Based on Weiss Multi-Strategy Advisers's 13F filing for Q1 2024.